Jennifer Taylor on August 1, 2026 3:22 pm If AISC keeps dropping, this becomes investable for me. Reply
James Hernandez on August 1, 2026 3:22 pm Exploration results look promising, but permitting will be the key risk. Reply
Jennifer Brown on August 1, 2026 3:23 pm Exploration results look promising, but permitting will be the key risk. Reply
Lucas Rodriguez on August 1, 2026 3:24 pm If AISC keeps dropping, this becomes investable for me. Reply
Lucas Moore on August 1, 2026 3:27 pm Silver leverage is strong here; beta cuts both ways though. Reply
Elijah Taylor on August 1, 2026 3:28 pm Interesting update on Combat Vets from Israel Explain Urban Warfare, Drones, Insurgency tactics. Curious how the grades will trend next quarter. Reply
Robert Smith on August 1, 2026 3:29 pm The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Lucas Lee on August 1, 2026 3:29 pm Silver leverage is strong here; beta cuts both ways though. Reply
Robert Martin on August 1, 2026 3:30 pm Exploration results look promising, but permitting will be the key risk. Reply
Michael Thompson on August 1, 2026 3:32 pm Uranium names keep pushing higher—supply still tight into 2026. Reply
Elizabeth Hernandez on August 1, 2026 3:34 pm Exploration results look promising, but permitting will be the key risk. Reply
Oliver O. Martin on August 1, 2026 3:34 pm Exploration results look promising, but permitting will be the key risk. Reply
Elijah White on August 1, 2026 3:34 pm Interesting update on Combat Vets from Israel Explain Urban Warfare, Drones, Insurgency tactics. Curious how the grades will trend next quarter. Reply
Patricia Lopez on August 1, 2026 3:35 pm Exploration results look promising, but permitting will be the key risk. Reply
Olivia Johnson on August 1, 2026 3:35 pm Interesting update on Combat Vets from Israel Explain Urban Warfare, Drones, Insurgency tactics. Curious how the grades will trend next quarter. Reply
Lucas O. Rodriguez on August 1, 2026 3:35 pm The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
33 Comments
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Interesting update on Combat Vets from Israel Explain Urban Warfare, Drones, Insurgency tactics. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Uranium names keep pushing higher—supply still tight into 2026.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Interesting update on Combat Vets from Israel Explain Urban Warfare, Drones, Insurgency tactics. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
If AISC keeps dropping, this becomes investable for me.
Good point. Watching costs and grades closely.
Interesting update on Combat Vets from Israel Explain Urban Warfare, Drones, Insurgency tactics. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.